New Collaboration: Scribe Therapeutics and Biogen to Explore CRISPR-Related Therapies for ALS

On October 6, 2020, molecular engineering company Scribe Therapeutics announced an exciting partnership. Originally founded by molecular engineers and CRISPR inventors, Scribe Therapeutics seeks to develop in vivo genetic medicine to treat…

Continue Reading New Collaboration: Scribe Therapeutics and Biogen to Explore CRISPR-Related Therapies for ALS